Skip to search.
 FTSE 100 Up 0.70%

More On SKP.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Skyepharma PLC (SKP.L)

-LSE Ticker: 3BFNB6/ISIN: GB00B3BFNB64
470.00 Up 1.25(0.27%) 25 May 16:38
Prev Close:468.75
Open:469.00
Bid:469.75 x 1500000
Ask:470.25 x 270000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:464.75 - 471.50
52wk Range:249.25 - 486.25
Volume:426,298
Avg Vol (3m):338,337
Market Cap:497.31m
P/E (ttm):19.11
EPS (ttm):24.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.18
P/S (ttm):511.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :19.75
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC develops and sells oral and inhalation pharmaceutical products worldwide. The company’s inhalation products include flutiform, an inhalation drug for asthma; and Relvar Ellipta/Breo Ellipta, Anoro Ellipta, and Incruse Ellipta, ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback